To investigate the roles of BDNF-TrkB signaling in the prophylactic effects of (R)-ketamine on LPS-induced depression-like phenotype, TrkB antagonist ANA-12 (0.5 mg/kg) was injected to mice 30 min before injection of (R)-ketamine (Figure S3). The gene discussed is NTRK2; the disease is depressive disorder.